NRAS and neoplasm: Subsequent comparisons of genomic profiles from an additional twelve LGSC cell models showed frequent deletion of Chr9p (including loss of MTAP and CDKN2A genes) [48, 49] and oncogenic mutations in KRAS and NRAS genes, in agreement with results from previous studies on LGSC tumor tissues [13–15].